Read More Pharma Industry News Agenus announces promising trial results for colon cancer treatment at ESMO Congress Agenus Inc. (Nasdaq: AGEN), a pioneer in the development of immunological agents for cancer treatment, has recently unveiled… byPallavi MadhirajuJune 29, 2024